🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 22 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/05/1988 | 8,02 | 8,02 | 7,85 | 7,87 | -1,98% | 2,15% | 5.572.426 |
| 17/05/1988 | 8,09 | 8,10 | 8,01 | 8,02 | -0,25% | 1,06% | 6.181.733 |
| 16/05/1988 | 8,00 | 8,06 | 8,00 | 8,04 | +0,91% | 0,75% | 5.613.926 |
| 13/05/1988 | 7,96 | 7,99 | 7,95 | 7,97 | +0,59% | 0,58% | 3.863.347 |
| 12/05/1988 | 7,96 | 7,97 | 7,91 | 7,93 | -0,33% | 0,75% | 4.061.419 |
| 11/05/1988 | 7,98 | 7,99 | 7,89 | 7,95 | -1,72% | 1,33% | 12.003.163 |
| 10/05/1988 | 8,11 | 8,14 | 8,06 | 8,09 | +0,25% | 0,90% | 5.759.179 |
| 09/05/1988 | 7,98 | 8,10 | 7,98 | 8,07 | +0,16% | 1,49% | 6.675.970 |
| 06/05/1988 | 8,24 | 8,27 | 8,06 | 8,06 | -2,09% | 2,57% | 8.298.274 |
| 05/05/1988 | 8,30 | 8,31 | 8,22 | 8,23 | -1,19% | 1,04% | 5.759.179 |
| 04/05/1988 | 8,43 | 8,44 | 8,32 | 8,33 | -1,26% | 1,34% | 3.453.998 |
| 03/05/1988 | 8,40 | 8,44 | 8,39 | 8,44 | +0,87% | 0,63% | 4.101.034 |
| 02/05/1988 | 8,39 | 8,41 | 8,34 | 8,36 | +0,24% | 0,87% | 3.478.522 |
| 29/04/1988 | 8,38 | 8,39 | 8,30 | 8,34 | -0,47% | 1,11% | 6.013.843 |
| 28/04/1988 | 8,42 | 8,43 | 8,35 | 8,38 | -0,08% | 0,95% | 4.261.378 |
| 27/04/1988 | 8,38 | 8,44 | 8,38 | 8,39 | +0,00% | 0,79% | 7.362.619 |
| 26/04/1988 | 8,33 | 8,43 | 8,32 | 8,39 | +0,96% | 1,27% | 8.362.411 |
| 25/04/1988 | 8,30 | 8,34 | 8,28 | 8,31 | +0,40% | 0,72% | 6.408.101 |
| 22/04/1988 | 8,32 | 8,35 | 8,28 | 8,28 | -0,08% | 0,88% | 5.004.619 |
| 21/04/1988 | 8,37 | 8,47 | 8,22 | 8,28 | -0,79% | 3,01% | 10.633.637 |
| 20/04/1988 | 8,33 | 8,39 | 8,30 | 8,35 | -0,32% | 1,03% | 11.401.402 |
| 19/04/1988 | 8,48 | 8,53 | 8,38 | 8,38 | +0,16% | 1,88% | 11.539.109 |
| 18/04/1988 | 8,40 | 8,43 | 8,36 | 8,36 | -1,33% | 0,87% | 6.474.125 |
| 15/04/1988 | 8,50 | 8,51 | 8,35 | 8,48 | +0,16% | 1,87% | 13.570.762 |
| 14/04/1988 | 8,64 | 8,76 | 8,46 | 8,46 | -4,56% | 3,53% | 20.373.120 |
| 13/04/1988 | 8,83 | 8,87 | 8,72 | 8,87 | +0,30% | 1,65% | 6.268.507 |
| 12/04/1988 | 8,78 | 8,85 | 8,75 | 8,84 | +0,83% | 1,21% | 6.526.944 |
| 11/04/1988 | 8,77 | 8,84 | 8,75 | 8,77 | +0,30% | 1,06% | 10.726.070 |
| 08/04/1988 | 8,56 | 8,75 | 8,56 | 8,74 | +2,09% | 2,17% | 12.286.123 |
| 07/04/1988 | 8,48 | 8,59 | 8,48 | 8,56 | +0,94% | 1,33% | 10.705.320 |